Toggle navigation
About Boston Biomedical
Leadership
History
Contact
Our Science
Cancer Stem Cells
- STAT3 Pathway
WT1
Resources
Our Pipeline
CanStem 111P Trial
CanStem 303C Trial
Wizard 201G Trial
Publications
News & Media
Careers
Current Opportunities
Boston Biomedical, Inc. Chief Executive Officer Patricia S. Andrews Appointed to Board of Directors of GlycoMimetics
Read more
here
.